发明名称 |
Treatment of Acinetobacter with alginate oligomers and antibiotics |
摘要 |
The invention provides a method to improve the efficacy of an antibiotic to inhibit the growth of Acinetobacter, said method comprising using said antibiotic together with an alginate oligomer. The Acinetobacter may be on an animate or inanimate surface and both medical and non-medical uses and methods are provided. In one aspect the invention provides an alginate oligomer for use together with at least one antibiotic in treating a subject infected, suspected to be infected, or at risk of infection, with Acinetobacter. In another aspect the method can be used to combat Acinetobacter contamination of a site e.g., for disinfection and cleaning purposes. |
申请公布号 |
US8815831(B2) |
申请公布日期 |
2014.08.26 |
申请号 |
US201013376140 |
申请日期 |
2010.06.03 |
申请人 |
Algipharma AS |
发明人 |
Onsoyen Edvar;Myrvold Rolf;Dessen Arne;Thomas David;Walsh Timothy Rutland |
分类号 |
A61K31/734;A61K31/715;A61K31/7048;A61K31/7042;A61K31/7036;A61P31/00;A61P31/04 |
主分类号 |
A61K31/734 |
代理机构 |
Knobbe, Martens, Olson & Bear, LLP |
代理人 |
Knobbe, Martens, Olson & Bear, LLP |
主权项 |
1. A method of reducing Acinetobacter, said method comprising contacting said Acinetobacter with an antibiotic together with an alginate oligomer, wherein the antibiotic is selected from the group consisting of a macrolide, a β-lactam, a tetracycline, and a quinolone. |
地址 |
Sandvika NO |